FDA Inspection
Tris Pharma Inc.Tris Pharma Inc. – FDA Inspection, Jan 23, 2019
Record Details
This FDA Inspection record concerns Tris Pharma Inc., with an inspection on January 23, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 2d9231c8-f86c-4a28-96c0-54d7c9c16c2c
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1076980
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.166(a)Written program not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Tris Pharma Inc.
13| Date | Classification | Office | Project area |
|---|---|---|---|
| November 21, 2025 | VAI | New Jersey District Office | Drug Quality Assurance |
| March 8, 2024 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 8, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 16, 2018 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| March 20, 2017 | OAI | Center for Drug Evaluation and Research | New Drug Evaluation |
Other documents for Tris Pharma Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.